- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2052-3211
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Big data, medicines safety and pharmacovigilance ; volume:14 ; number:1 ; day:2 ; month:6 ; year:2021 ; pages:1-3 ; date:12.2021
Journal of pharmaceutical policy and practice ; 14, Heft 1 (2.6.2021), 1-3, 12.2021
- Creator
-
Hussain, Rabia
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s40545-021-00329-4
- URN
-
urn:nbn:de:101:1-2021092619173804493750
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:34 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Hussain, Rabia
- SpringerLink (Online service)
Other Objects (12)
Overview on pharmacovigilance of nephrotoxic herbal medicines used worldwide
Effectiveness of a structured stimulated spontaneous safety monitoring of medicines reporting program in strengthening pharmacovigilance system in Tanzania
Safety of Nintedanib in Patients with Idiopathic Pulmonary Fibrosis: Global Pharmacovigilance Data
Safety of factor XIII concentrate : analysis of more than 20 years of pharmacovigilance data
Pharmacovigilance Agreements: Negotiating Safety Data Exchange Timelines: To Agree to Disagree? That is the Question
Safety of Antiplatelet Agents: Analysis of ‘Real-World’ Data from the Italian National Pharmacovigilance Network
Anti-Counterfeiting in Global Pharmacovigilance : A Question of Patient Safety
Improved drug safety through intensive pharmacovigilance in hospitalized pediatric patients
Artificial intelligence, big data, and blockchain in food safety
Post-marketing safety concerns with rimegepant based on a pharmacovigilance study
Big data, big responsibilities
Big Data - Big Business?
Overview on pharmacovigilance of nephrotoxic herbal medicines used worldwide
Effectiveness of a structured stimulated spontaneous safety monitoring of medicines reporting program in strengthening pharmacovigilance system in Tanzania
Safety of Nintedanib in Patients with Idiopathic Pulmonary Fibrosis: Global Pharmacovigilance Data
Safety of factor XIII concentrate : analysis of more than 20 years of pharmacovigilance data
Pharmacovigilance Agreements: Negotiating Safety Data Exchange Timelines: To Agree to Disagree? That is the Question
Safety of Antiplatelet Agents: Analysis of ‘Real-World’ Data from the Italian National Pharmacovigilance Network
Anti-Counterfeiting in Global Pharmacovigilance : A Question of Patient Safety
Improved drug safety through intensive pharmacovigilance in hospitalized pediatric patients
Artificial intelligence, big data, and blockchain in food safety
Post-marketing safety concerns with rimegepant based on a pharmacovigilance study
Big data, big responsibilities
Big Data - Big Business?
Overview on pharmacovigilance of nephrotoxic herbal medicines used worldwide
Effectiveness of a structured stimulated spontaneous safety monitoring of medicines reporting program in strengthening pharmacovigilance system in Tanzania
Safety of Nintedanib in Patients with Idiopathic Pulmonary Fibrosis: Global Pharmacovigilance Data
Safety of factor XIII concentrate : analysis of more than 20 years of pharmacovigilance data
Pharmacovigilance Agreements: Negotiating Safety Data Exchange Timelines: To Agree to Disagree? That is the Question
Safety of Antiplatelet Agents: Analysis of ‘Real-World’ Data from the Italian National Pharmacovigilance Network
Anti-Counterfeiting in Global Pharmacovigilance : A Question of Patient Safety
Improved drug safety through intensive pharmacovigilance in hospitalized pediatric patients
Artificial intelligence, big data, and blockchain in food safety
Post-marketing safety concerns with rimegepant based on a pharmacovigilance study
Big data, big responsibilities